Cancers, Free Full-Text

Por um escritor misterioso

Descrição

The use of multiparametric magnetic resonance imaging (mpMRI) has become a common technique used in guiding biopsy and developing treatment plans for prostate lesions. While this technique is effective, non-invasive methods such as radiomics have gained popularity for extracting imaging features to develop predictive models for clinical tasks. The aim is to minimize invasive processes for improved management of prostate cancer (PCa). This study reviews recent research progress in MRI-based radiomics for PCa, including the radiomics pipeline and potential factors affecting personalized diagnosis. The integration of artificial intelligence (AI) with medical imaging is also discussed, in line with the development trend of radiogenomics and multi-omics. The survey highlights the need for more data from multiple institutions to avoid bias and generalize the predictive model. The AI-based radiomics model is considered a promising clinical tool with good prospects for application.
Cancers, Free Full-Text
from Flow Cytometry to Cytomics, Page 2
Cancers, Free Full-Text
Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study - The Lancet Digital Health
Cancers, Free Full-Text
Cancer-Free with Food: A Step-by-Step by Werner Gray, Liana
Cancers, Free Full-Text
Home - Free ME from Lung Cancer
Cancers, Free Full-Text
Thoracic Cancer - Wiley Online Library
Cancers, Free Full-Text
Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization
Cancers, Free Full-Text
PDF) Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients
Cancers, Free Full-Text
Free Prostate Cancer Screening In Michigan - Colaboratory
Cancers, Free Full-Text
PDF) Detection of label-free cancer biomarkers using nickel nanoislands and quartz crystal microbalance
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
de por adulto (o preço varia de acordo com o tamanho do grupo)